September 6, 2022:

Eylea maker Regeneron looks to raise eye health awareness with ‘Now Eye See’ campaign | Fierce Pharma

September 2, 2022:

Biogen bails on AGTC after ocular gene therapy flunks trial | Fierce Biotech

August 29, 2022:

At-Home COVID Tests, Accessible for People Who Are Blind or Have Low Vision, Now Available

August 26, 2022:

AbbVie bets $370M on pivotal eye disease gene therapy, puts up $1.4B in biobucks | Fierce Biotech

August 15, 2022:

Opinion: Awareness-raising is key to deliver eye health for all by 2030 | Devex

 

August 1, 2022:

Testosterone therapy improves quality of life in men with hypogonadism, type 2 diabetes